physostigmine has been researched along with Cholera Infantum in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 5 (83.33) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (16.67) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Birkhed, D; Ekström, J; Khosravani, N | 1 |
| Domino, EF; Kothary, SP; Pandit, SK; Pandit, UA; Samra, SK | 1 |
| Fuchs, HF; Maeder, HU | 1 |
| Baker, LH; Corbett, T; Pazdur, R; Phillips, M; Redman, BG | 1 |
| Upson, DW | 1 |
| Bartek, I; Czirbusz, G; Farkas, S; Földi, I; Németh-Csóka, M; Póka, L | 1 |
1 review(s) available for physostigmine and Cholera Infantum
| Article | Year |
|---|---|
Pharmacologic principles of gastrointestinal therapy.
Topics: Acetylcholine; Animals; Antacids; Anti-Bacterial Agents; Anti-Inflammatory Agents; Antiemetics; Antipsychotic Agents; Caffeine; Carbachol; Cathartics; Cholagogues and Choleretics; Digestive System; Dogs; Drug Interactions; Emetics; Gastric Juice; Gastrointestinal Diseases; Gastrointestinal Motility; Histamine; Histamine H1 Antagonists; Hypnotics and Sedatives; Norepinephrine; Phenothiazines; Physostigmine; Sulfonamides | 1973 |
1 trial(s) available for physostigmine and Cholera Infantum
| Article | Year |
|---|---|
The cholinesterase inhibitor physostigmine for the local treatment of dry mouth: a randomized study.
Topics: Administration, Topical; Adult; Aged; Cholinesterase Inhibitors; Cross-Over Studies; Dose-Response Relationship, Drug; Double-Blind Method; Female; Gastrointestinal Diseases; Gels; Humans; Lip; Male; Middle Aged; Mouth Mucosa; Physostigmine; Placebos; Safety; Saliva; Salivation; Time Factors; Treatment Outcome; Xerostomia; Young Adult | 2009 |
4 other study(ies) available for physostigmine and Cholera Infantum
| Article | Year |
|---|---|
Physostigmine fails to reverse clinical, psychomotor, or EEG effects of lorazepam.
Topics: Adult; Anti-Anxiety Agents; Brain; Cardiovascular Diseases; Double-Blind Method; Electroencephalography; Female; Gastrointestinal Diseases; Glycopyrrolate; Humans; Hypnotics and Sedatives; Lorazepam; Male; Memory; Physostigmine; Psychomotor Performance | 1983 |
[Pharmacoradiography of the gastro intestinal tract (author's transl)].
Topics: Atropine; Butylscopolammonium Bromide; Gastrointestinal Diseases; Gastrointestinal Motility; Glucagon; Humans; Metoclopramide; Morphine; Oxyphenonium; Parasympatholytics; Physostigmine; Propantheline; Radiography | 1976 |
Phase I trial of spiromustine (NSC 172112) and evaluation of toxicity and schedule in a murine model.
Topics: Animals; Antineoplastic Agents; Cognition Disorders; Consciousness Disorders; Drug Evaluation; Drug Evaluation, Preclinical; Gastrointestinal Diseases; Humans; Hydantoins; Mice; Mice, Inbred Strains; Neoplasms; Nitrogen Mustard Compounds; Physostigmine; Speech Disorders | 1987 |
Absorption of 131-I-triolein in postoperative gastrointestinal paralysis.
Topics: Amylases; Animals; Biological Transport; Dogs; Feces; Gastrointestinal Diseases; Gastrointestinal Motility; Intestinal Absorption; Iodine Isotopes; Laparotomy; Lipase; Paralysis; Physostigmine; Postoperative Complications; Triglycerides; Triolein; Trypsin | 1967 |